Lessons from the COVID-19 pandemic for improving outpatient neuropalliative care: A qualitative study of patient and caregiver perspectives.


Journal

Palliative medicine
ISSN: 1477-030X
Titre abrégé: Palliat Med
Pays: England
ID NLM: 8704926

Informations de publication

Date de publication:
07 2021
Historique:
pubmed: 20 5 2021
medline: 13 7 2021
entrez: 19 5 2021
Statut: ppublish

Résumé

COVID-19 has impacted persons with serious illness, including those with chronic, neurodegenerative conditions. While there are several reports on COVID-19's impact on inpatient palliative care, literature is limited about the impact on outpatient care which may be more relevant for these patients. To generate a person-centered description of the impact of COVID-19 from the perspectives of patients living with neurodegenerative disease and caregivers to improve outpatient palliative care delivery. This qualitative study used rapid analysis via matrix design to identify emergent themes related to participant perspectives on the challenges of COVID-19. Data sources included semi-structured interviews, open-ended survey responses, medical record documentation and participant-researcher communications. Data was collected from 108 patients with Parkinson's disease, Alzheimer's disease or related disorders and 90 caregivers enrolled in a multicenter, clinical trial of community-based, outpatient palliative care between March 20, 2020 and August 8, 2020 (NCT03076671). Four main themes emerged: (1) disruptions to delivery of healthcare and other supportive services; (2) increased symptomatic and psychosocial needs; (3) increased caregiver burden; (4) limitations of telecommunications when compared to in-person contact. We observed that these themes interacted and intersected. Patients and caregivers have unmet care needs because of the pandemic, exacerbated by social isolation. While telemedicine has helped improve access to healthcare, patients and caregivers perceive clear limitations compared to in-person services. Changes in society and healthcare delivery in response to COVID-19 highlight ongoing and novel gaps that must be addressed to optimize future outpatient palliative care for neurologic illness.

Sections du résumé

BACKGROUND
COVID-19 has impacted persons with serious illness, including those with chronic, neurodegenerative conditions. While there are several reports on COVID-19's impact on inpatient palliative care, literature is limited about the impact on outpatient care which may be more relevant for these patients.
AIM
To generate a person-centered description of the impact of COVID-19 from the perspectives of patients living with neurodegenerative disease and caregivers to improve outpatient palliative care delivery.
DESIGN
This qualitative study used rapid analysis via matrix design to identify emergent themes related to participant perspectives on the challenges of COVID-19. Data sources included semi-structured interviews, open-ended survey responses, medical record documentation and participant-researcher communications.
SETTING/PARTICIPANTS
Data was collected from 108 patients with Parkinson's disease, Alzheimer's disease or related disorders and 90 caregivers enrolled in a multicenter, clinical trial of community-based, outpatient palliative care between March 20, 2020 and August 8, 2020 (NCT03076671).
RESULTS
Four main themes emerged: (1) disruptions to delivery of healthcare and other supportive services; (2) increased symptomatic and psychosocial needs; (3) increased caregiver burden; (4) limitations of telecommunications when compared to in-person contact. We observed that these themes interacted and intersected.
CONCLUSIONS
Patients and caregivers have unmet care needs because of the pandemic, exacerbated by social isolation. While telemedicine has helped improve access to healthcare, patients and caregivers perceive clear limitations compared to in-person services. Changes in society and healthcare delivery in response to COVID-19 highlight ongoing and novel gaps that must be addressed to optimize future outpatient palliative care for neurologic illness.

Identifiants

pubmed: 34006157
doi: 10.1177/02692163211017383
pmc: PMC9447864
mid: NIHMS1831334
doi:

Banques de données

ClinicalTrials.gov
['NCT03076671']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1258-1266

Subventions

Organisme : NIA NIH HHS
ID : K02 AG062745
Pays : United States
Organisme : NINR NIH HHS
ID : R01 NR016037
Pays : United States
Organisme : NIA NIH HHS
ID : T32 AG044296
Pays : United States

Références

NPJ Parkinsons Dis. 2020 Oct 8;6:28
pubmed: 33083522
J Pain Symptom Manage. 2020 Jul;60(1):e21-e26
pubmed: 32240754
Int J Geriatr Psychiatry. 2019 Aug;34(8):1128-1138
pubmed: 31069845
Oncol Nurs Forum. 2014 Sep;41(5):545-7
pubmed: 25158659
J Geriatr Psychiatry Neurol. 2011 Dec;24(4):229-34
pubmed: 22228830
Dialogues Clin Neurosci. 2009;11(2):217-28
pubmed: 19585957
Int J Nurs Stud. 2021 Jan;113:103781
pubmed: 33080475
BMJ. 2016 Apr 18;353:i2171
pubmed: 27090749
J Pain Symptom Manage. 2022 May;63(5):e563-e564
pubmed: 32976945
Palliat Med. 2019 Apr;33(4):415-429
pubmed: 30854933
JAMA. 2020 Aug 4;324(5):445-446
pubmed: 32639547
N Engl J Med. 2020 Jun 11;382(24):2368-2371
pubmed: 32302076
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346
pubmed: 32214079
Qual Health Res. 2002 Jul;12(6):855-66
pubmed: 12109729
Neurology. 2018 Jul 31;91(5):217-226
pubmed: 29950434
Alzheimers Dement. 2021 Aug;17(8):1297-1306
pubmed: 33559975
Telemed J E Health. 2021 Jan;27(1):102-106
pubmed: 32644899
Ann Palliat Med. 2020 Feb;9(Suppl 1):S24-S33
pubmed: 31735048
JAMA Neurol. 2020 Aug 1;77(8):927-928
pubmed: 32329796
JAMA. 2020 Sep 22;324(12):1139-1140
pubmed: 32960246
Qual Health Res. 2015 Sep;25(9):1212-22
pubmed: 26184336
J Pain Symptom Manage. 2020 Jul;60(1):e18-e20
pubmed: 32247056
J Parkinsons Dis. 2020;10(2):351-354
pubmed: 32250324
Br J Community Nurs. 2014 Mar;19(3):136-41
pubmed: 24897835
Am J Geriatr Psychiatry. 2020 Sep;28(9):993-998
pubmed: 32576424
Ann Palliat Med. 2018 Jul;7(3):339-348
pubmed: 29307208
JAMA. 2020 Oct 20;324(15):1562-1564
pubmed: 33044483
MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250-1257
pubmed: 32915166
BMC Public Health. 2020 Aug 1;20(1):1193
pubmed: 32738884
PLoS One. 2015 Jul 08;10(7):e0132168
pubmed: 26154626
J Psychosoc Nurs Ment Health Serv. 2018 Oct 1;56(10):36-43
pubmed: 29667698
JAMA Neurol. 2020 May 1;77(5):551-560
pubmed: 32040141

Auteurs

Zachary A Macchi (ZA)

Department of Neurology, University of Colorado Anschutz, Aurora, CO, USA.
Department of Internal Medicine, University of Colorado Anschutz, Aurora, CO, USA.

Roman Ayele (R)

College of Nursing, University of Colorado Anschutz, Aurora, CO, USA.

Megan Dini (M)

Department of Neurology, University of Colorado Anschutz, Aurora, CO, USA.

Jensine Lamira (J)

Department of Cell & Developmental Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Maya Katz (M)

Department of Neurology, University of California San Francisco, San Francisco, CA, USA.

Steven Z Pantilat (SZ)

Department of Medicine, University of California San Francisco, San Francisco, CA, USA.

Jacqueline Jones (J)

College of Nursing, University of Colorado Anschutz, Aurora, CO, USA.

Benzi M Kluger (BM)

Departments of Neurology and Medicine, University of Rochester Medical Center, Rochester, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH